Clinical trial
A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft…
NCT02910895 · The Netherlands Cancer Institute, Other · Recruiting
Key facts
| NCT number | NCT02910895 |
|---|---|
| Title | A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) |
| Official title | Development of a Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS): Protocol to Obtain Tumour Material From Patients With STS. |
| Acronym | SarcomaPDX |
| Lead sponsor | The Netherlands Cancer Institute, Other |
| Collaborators | KU Leuven |
| Status | Recruiting |
| Study type | Interventional |
| Conditions | Soft Tissue Sarcoma, Xenograft Model, 2D/3D Cell Cultures |
| Intervention type | Other |
| Interventions | tumor biopsy |
| Enrollment | 40 |
| Start date | Sep 9, 2017 |
| Primary completion | Sep 1, 2024 |
| Completion | Sep 1, 2024 |
| First posted | Sep 22, 2016 |
| Last update posted | Jun 7, 2024 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: